Hepatocellular Carcinoma Cancer Inflammation, Immunity and Senescence with Michael Karin, Phd AACR IO 2025 AACR 4 Mins Read February 26, 2025 | By Michael Karin, PhdLiver cancer, specifically hepatocellular carcinoma (HCC), is on the rise—and a sneaky culprit…
Ghassan Abou-Alfa, MD – HIMALAYA Phase III trial – Tremelimumab accepted under Priority Review in the US for patients with unresectable liver cancer in combination with Imfinzi.m4v Liver 3 Mins Read Dr. Ghassan Abu Alfa, MD with Memorial Sloan Kettering Cancer Center in New York, provides an update on the key…
